Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,248
Closed -$39.6K 4623
2023
Q1
$39.6K Buy
2,248
+625
+39% +$32.2K ﹤0.01% 4067
2022
Q4
$84.4K Buy
1,623
+1,083
+201% +$78.7K ﹤0.01% 4389
2022
Q3
$45K Sell
540
-493
-48% -$65.4K ﹤0.01% 4702
2022
Q2
$150K Sell
1,033
-19,324
-95% -$2.81M ﹤0.01% 4642
2022
Q1
$3.14M Buy
+20,357
New +$4.52M ﹤0.01% 2842
2021
Q4
Sell
-1,242
Closed -$811K 5762
2021
Q3
$811K Buy
+1,242
New +$1.09M ﹤0.01% 3767

Other funds holding NEUE

David Shaw's NEUE Position: Q2 2023 in Review

David Shaw sold out of NeueHealth (NEUE) in Q2 2023, closing a stake of 2,248 shares — an estimated $39.6K sold.

David Shaw first reported a position in NEUE in Q3 2021 and held it in 6 quarters. The position peaked at $3.14M in Q1 2022. 49 funds tracked by Wall St. Rank hold NEUE as of Q2 2023.

  • David Shaw reported no remaining NeueHealth position as of Q2 2023 after selling out during the quarter.
  • David Shaw sold 2,248 NeueHealth shares in Q2 2023, an estimated $39.6K.
  • David Shaw first reported a position in NeueHealth in Q3 2021 and held it in 6 quarters.
  • David Shaw's NeueHealth position peaked at $3.14M in Q1 2022.
  • 49 funds tracked by Wall St. Rank held NeueHealth as of Q2 2023.

Based on D.E. Shaw & Co's 13F filing for Q2 2023, filed 14 Aug 2023.